Orrick Advises Catalyst Biosciences, Inc. on Follow-On Offering

February.18.2020

Orrick advised Catalyst Biosciences, Inc. (Nasdaq: CBIO), a clinical-stage biopharmaceutical company developing novel treatments for hemophilia and other rare bleeding disorders, on its follow-on offering of 5,307,692 shares of common stock. The gross proceeds to Catalyst Biosciences, Inc. from the offering were approximately $34.5 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Catalyst Biosciences, Inc. Raymond James & Associates, Inc. acted as the sole book-running manager and JonesTrading Institutional Services LLC, Chardan and LifeSci Capital LLC acted as co-managers for the offering. The offering closed on February 18, 2020.

The Orrick team advising Catalyst Biosciences, Inc. was led by capital markets partners Stephen Thau and Niki Fang and included associates Kelly Mink and Sean Carfi.

Related Lawyers

Stephen Thau Partner, Technology Companies Group, Life Sciences

New York; Silicon Valley

See my bio

D:+1 212 506 5076
E: [email protected]

Practice:

Technology & Innovation Sector
Technology Companies Group
Life Sciences
Mergers & Acquisitions
Corporate Governance
Capital Markets

vCard

See full bio

Stephen Thau Partner

New York; Silicon Valley

Stephen’s practice focuses on the representation of life science, medical device, health IT, and other technology companies in transactional matters, including public and private financings, licensing, collaborations and strategic alliances, and mergers and acquisitions. He also represents venture capital firms in public and private financing transactions.

Stephen is recognized as a Leading Life Sciences Lawyer by LMG Life Sciences in their 2021/2022 rankings and short-listed as Venture Capital Attorney of the Year. He has served as a member of the Board of Tech Council of Maryland, the leading technology and life science association in that state, and of BayBio, Northern California’s leading life sciences association. Stephen is a frequent speaker on venture capital financings and served on the faculty at the 2005 and 2007 Emerging Entrepreneurs workshops at Stanford University.

Prior to joining Orrick, Stephen was a partner at Morrison & Foerster, Venture Law Group and Heller Ehrman. He began his legal practice as a litigator, focusing on securities and intellectual property. ;He also served as a law clerk to the Hon. Vaughn R. Walker in the United States District Court in the Northern District of California. Stephen graduated Order of the Coif from Stanford Law School, where he was managing editor of the Stanford Law Review, and graduated magna cum laude from Harvard College in Biology.

Niki Fang Partner, Capital Markets, Technology Companies Group

San Francisco

See my bio

D:+1 415 773 5540
E: [email protected]

Practice:

Capital Markets
Technology Companies Group
Special Purpose Acquisition Companies (SPACs)

vCard

See full bio

Niki Fang Partner

San Francisco

Niki concentrates her corporate practice on representing issuers and underwriters in public offerings and capital markets transactions. Niki also regularly counsels public and late-stage private companies on securities law compliance, disclosure matters, SEC reporting obligations, corporate governance and stock exchange listing obligations. In addition, Niki’s practice includes venture capital financings and advising start-up companies on general corporate matters. She represents a wide range of technology and life sciences companies, from privately held start-ups to publicly traded corporations.

Prior to joining Orrick, Niki was at Fenwick & West LLP and Davis Polk & Wardwell LLP.